{"title":"两种治疗慢性阻塞性肺疾病的有效药物噻托溴铵和罗氟司特的分析","authors":"Yuanzi Xu","doi":"10.1145/3570773.3570833","DOIUrl":null,"url":null,"abstract":"Chronic obstructive pulmonary disease (COPD) is characterized by consistent airway obstruction, which is mainly caused by bronchoconstriction and airway inflammation. Two recommended medications, tiotropium bromide (TIO) and roflumilast, exert their pharmacological effects of bronchodilation and anti-inflammation respectively. This review's purpose is to elucidate two drug therapies, TIO and roflumilast for COPD comprehensively, therefore their pharmacodynamic, pharmacology and pharmacokinetic properties are reviewed. Both once-daily administration of tiotropium and roflumilast demonstrate improvement of patients’ lung function, suggesting their good potency to treat COPD.","PeriodicalId":153475,"journal":{"name":"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Analysis of Tiotropium bromide and Roflumilast: Two Potent Medications for Chronic Obstructive Pulmonary Disease\",\"authors\":\"Yuanzi Xu\",\"doi\":\"10.1145/3570773.3570833\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Chronic obstructive pulmonary disease (COPD) is characterized by consistent airway obstruction, which is mainly caused by bronchoconstriction and airway inflammation. Two recommended medications, tiotropium bromide (TIO) and roflumilast, exert their pharmacological effects of bronchodilation and anti-inflammation respectively. This review's purpose is to elucidate two drug therapies, TIO and roflumilast for COPD comprehensively, therefore their pharmacodynamic, pharmacology and pharmacokinetic properties are reviewed. Both once-daily administration of tiotropium and roflumilast demonstrate improvement of patients’ lung function, suggesting their good potency to treat COPD.\",\"PeriodicalId\":153475,\"journal\":{\"name\":\"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1145/3570773.3570833\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1145/3570773.3570833","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Analysis of Tiotropium bromide and Roflumilast: Two Potent Medications for Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is characterized by consistent airway obstruction, which is mainly caused by bronchoconstriction and airway inflammation. Two recommended medications, tiotropium bromide (TIO) and roflumilast, exert their pharmacological effects of bronchodilation and anti-inflammation respectively. This review's purpose is to elucidate two drug therapies, TIO and roflumilast for COPD comprehensively, therefore their pharmacodynamic, pharmacology and pharmacokinetic properties are reviewed. Both once-daily administration of tiotropium and roflumilast demonstrate improvement of patients’ lung function, suggesting their good potency to treat COPD.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
